Residual Scope: A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients

Badgett, James (PI)
Bayliff, Sherry (Former CoI)
D'Orazio, John (Former CoI)
Geil, John (Former CoI)
Radulescu, Vlad (Former CoI)
Shaw, Angela (Former CoI)
Sorge, Caryn (Former CoI)

Pediatrics

1 Finished

1 results

Finished
A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphobl
Badgett, J., Bayliff, S., D'Orazio, J., Geil, J., Radulescu, V., Shaw, A. & Sorge, C.
Public Health Institute
6/28/19 → 9/7/24
Project: Research project